Member Info for violindog

Burble, wish you a speedy recovery. Remember to lie down on your front for an hour or two each day/night. Take a really deep breath and when you think you have inhaled to your max ..then try a quick "sniff" via your nose. Work those lungs ...

Hasiba, thanks for your thoughts. You make a good case for investment at current levels. Your comment about "put them in the lower draw" gave me a chuckle.. as a seasoned SCLP investor something i am well experienced with. Hope ever eternal.

Well, thinking about it..50% off recent highs..guess what's not to like.

Hasiba, well done ..you have traded this well . Why do you think this is the floor ?

An update is indeed required. LD's comment s in the last Proactive interview- in relation to the Modi1 trial start- was misleading .

Just like the others....we will never know. More importantly in my opinion is how LONG these agreements take to evaluate the product before the pharma decides to make an offer or walk away.

This is good I presume..perhaps strengthening the argument HUR is going to be sold at a VERY healthy premium to the current price in the not too distant future to liquidate CAs position .

What on earth does this mean after falling almost 50 % from recent highs ? The only news we've had recently was the misleading Proactive interview.

With respect to Burble's comments....I think he underestates the "clout" of the lead clinician : Dr Christian Opp...Immunotherapy is his area and one of the reasons he holds his position. He should be keen to proceed. This delay is frustrating indeed.

AB, for me SCLP need to prove that they can transform from a research lab into a commercial biotechnology company and have the ability to run effective clinical trials. SCIB and Covidity hardly progressing and Modi1 not even in trial yet.
Since RG had his snout led back to the trough the share has lost around 25% ...transformational time indeed.

We know Modi1 is manufactured / LD has indicated on the Proactive interview all is ready at trial sites/ Christian Ottensmeier has the skill set / patients recently dosed for the Transgene trial...
.... so if the Modi1 trial hasn't by April 1st then taking into account the current progress with Scib and Covidity..... then I'm out.

Ottensmeier, Christian
Job Title: Professor in Immuno-oncology, Consultant in Medical Oncology
In the last three years his focus has increasingly become immunology and immunotherapy of head and neck cancer and lung cancers; these will be his clinical focus in Liverpool.

Integrated with his clinical practice, he runs a laboratory programme examining the role and interplay of innate and adaptive immune cells in lung cancer and head and neck cancer. This work is underpinned by systematic tissue collection, to which ~2000 patients have be recruited since 2015. He has a keen interested in developing early phase immunotherapy trials.

He manages a broad portfolio of clinical trials in solid cancers; he has co-developed a number of national NCRI studies in melanoma and lung cancer.

He has served on a number of national and international peer review committees as well as on advisory boards and DSMBs for industry led studies; he is a member Cancer Immunoguiding panel of the European “CIMT” collaborative, a member of EATI and of the editorial boards for the Journal of Translational Immunology, Cancer Immunology & Immunotherapy, and the newly founded open source BSI Journal “Immunotherapy Advances”.

Scancell....any news on the imminent start ???

Love the logo of Covidity. Also pleased about the offer of payment for time and expenses.

Hi C7 , yes, not OUR trial but it indicates the centre is "open" to trials. This centre is the lead centre for the Modi1 trial.
Not a mention of our trial in the recruitment section.
https://www.clatterbridgecc.nhs.uk/professionals/research-1/our-research/link-to-database

https://www.clatterbridgecc.nhs.uk/news/first-patient-given-vaccine-cancer-pioneering-clinical-research
So our trial centre is OPEN ...come on SCLP ...

Bob, they managed to get a pt dosed 4 days ago for Transgene at the very centre SCLP has signed up.
The Transgene study involves researchers from the University of Liverpool, The Clatterbridge Cancer Centre, Liverpool Head & Neck Centre and Liverpool University Hospitals.

At this rate we will soon be down to the SP we were before the announcement of Covidity and even RG has been lead back to the truogh !
The SP is hardly a reflection of the potential SCLP has but I guess with the delays (Covidity at 16 and Modi1 not yet started) there's no buying pressure and folks are selling looking to buy back cheaper . What else explains these daily declines.?

KonarA, that's the question of the moment. Why hasn't the trial for Modi1 started yet ?
If it's not up and running by Q1 then I'm looking to reduce my holding .

WHEN....the RNS lands giving news of the Modi1 trial start... the share price will (should) get a little boost . I expect that this will be announced during market hours rather than 007hrs if we use Covidity as a marker.